InsiderClue
Stocks · Health care · In Vitro & In Vivo Diagnostic Substances

NEOGEN CORP

NEOG Clue Score47
United States Fiscal year ends May CIK 0000711377
$11.85 +1.20% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $11.85 −71.11% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Revenue358.3Operating income64.9Net income43.8EPS, diluted0.86Fiscal year 2018Revenue397.9 +11.1%Operating income70.2Net income63.1 +44.2%EPS, diluted1.21Fiscal year 2019Revenue414.2 +4.1%Operating income68.1Net income60.2 −4.7%EPS, diluted0.57Fiscal year 2020Revenue418.2 +1.0%Operating income67.5Net income59.5 −1.2%EPS, diluted0.56Fiscal year 2021Revenue468.5 +12.0%Operating income74.2Net income60.9 +2.4%EPS, diluted0.57Fiscal year 2022Revenue527.2 +12.5%Operating income58.6Net income48.3 −20.7%EPS, diluted0.45Fiscal year 2023Revenue822.4 +56.0%Operating income37.5Net income−22.9 −147.3%EPS, diluted−0.12Fiscal year 2024Revenue924.2 +12.4%Operating income58.6Net income−9.4EPS, diluted−0.04Fiscal year 2025Revenue894.7 −3.2%Operating income−1,061.0Net income−1,092.0EPS, diluted−5.03Fiscal year 2026Revenue870.4 −2.7%Operating income−21.6Net income−7.9EPS, diluted−0.04
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue 358.3 397.9 414.2 418.2 468.5 527.2 822.4 924.2 894.7 870.4
Growth +11.1% +4.1% +1.0% +12.0% +12.5% +56.0% +12.4% −3.2% −2.7%
Operating income 64.9 70.2 68.1 67.5 74.2 58.6 37.5 58.6 −1,061.0 −21.6
Net income 43.8 63.1 60.2 59.5 60.9 48.3 −22.9 −9.4 −1,092.0 −7.9
Growth +44.2% −4.7% −1.2% +2.4% −20.7% −147.3%
EPS, diluted 0.86 1.21 0.57 0.56 0.57 0.45 −0.12 −0.04 −5.03 −0.04

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2017Gross margin47.1%Operating margin18.1%Net margin12.2%Free cash flow margin12.8%Fiscal year 2018Gross margin46.8%Operating margin17.6%Net margin15.9%Free cash flow margin12.1%Fiscal year 2019Gross margin46.3%Operating margin16.4%Net margin14.5%Free cash flow margin11.9%Fiscal year 2020Gross margin46.9%Operating margin16.1%Net margin14.2%Free cash flow margin14.8%Fiscal year 2021Gross margin45.9%Operating margin15.8%Net margin13.0%Free cash flow margin11.6%Fiscal year 2022Gross margin46.1%Operating margin11.1%Net margin9.2%Free cash flow margin8.3%Fiscal year 2023Gross margin49.4%Operating margin4.6%Net margin−2.8%Free cash flow margin−3.0%Fiscal year 2024Gross margin50.2%Operating margin6.3%Net margin−1.0%Free cash flow margin−8.2%Fiscal year 2025Gross margin47.1%Operating margin−118.6%Net margin−122.1%Free cash flow margin−5.2%Fiscal year 2026Gross margin46.9%Operating margin−2.5%Net margin−0.9%Free cash flow margin3.7%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Gross margin 47.1% 46.8% 46.3% 46.9% 45.9% 46.1% 49.4% 50.2% 47.1% 46.9%
Operating margin 18.1% 17.6% 16.4% 16.1% 15.8% 11.1% 4.6% 6.3% −118.6% −2.5%
Net margin 12.2% 15.9% 14.5% 14.2% 13.0% 9.2% −2.8% −1.0% −122.1% −0.9%
Free cash flow margin 12.8% 12.1% 11.9% 14.8% 11.6% 8.3% −3.0% −8.2% −5.2% 3.7%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow60.3Capital expenditure−14.6Free cash flow45.7Fiscal year 2018Operating cash flow69.1Capital expenditure−20.9Free cash flow48.2 +5.4%Fiscal year 2019Operating cash flow63.8Capital expenditure−14.7Free cash flow49.2 +2.1%Buybacks−3.1Fiscal year 2020Operating cash flow85.9Capital expenditure−24.1Free cash flow61.8 +25.7%Fiscal year 2021Operating cash flow81.1Capital expenditure−26.7Free cash flow54.4 −12.0%Fiscal year 2022Operating cash flow68.0Capital expenditure−24.4Free cash flow43.6 −19.8%Fiscal year 2023Operating cash flow41.0Capital expenditure−65.8Free cash flow−24.7 −156.7%Fiscal year 2024Operating cash flow35.3Capital expenditure−111.4Free cash flow−76.1Fiscal year 2025Operating cash flow58.2Capital expenditure−104.6Free cash flow−46.4Fiscal year 2026Operating cash flow83.2Capital expenditure−51.3Free cash flow31.9
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Operating cash flow 60.3 69.1 63.8 85.9 81.1 68.0 41.0 35.3 58.2 83.2
Capital expenditure −14.6 −20.9 −14.7 −24.1 −26.7 −24.4 −65.8 −111.4 −104.6 −51.3
Free cash flow 45.7 48.2 49.2 61.8 54.4 43.6 −24.7 −76.1 −46.4 31.9
Growth +5.4% +2.1% +25.7% −12.0% −19.8% −156.7%
Buybacks n/a n/a −3.1 n/a n/a n/a n/a n/a n/a n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2017Cash77.6Shareholders’ equity471.6Fiscal year 2018Cash83.1Shareholders’ equity560.2Fiscal year 2019Cash41.7Shareholders’ equity637.9Fiscal year 2020Cash66.3Shareholders’ equity725.2Fiscal year 2021Cash75.6Shareholders’ equity840.4Fiscal year 2022Cash44.5Total debt0.0Net cash (debt)44.5Shareholders’ equity887.4Debt to equity0.00Fiscal year 2023Cash163.2Total debt885.4Net cash (debt)−722.2Shareholders’ equity3,134.2Debt to equity0.28Fiscal year 2024Cash170.6Total debt890.8Net cash (debt)−720.2Shareholders’ equity3,144.1Debt to equity0.28Fiscal year 2025Cash129.0Total debt894.1Net cash (debt)−765.1Shareholders’ equity2,071.2Debt to equity0.43Fiscal year 2026Cash185.5Total debt793.7Net cash (debt)−608.2Shareholders’ equity2,092.9Debt to equity0.38
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash 77.6 83.1 41.7 66.3 75.6 44.5 163.2 170.6 129.0 185.5
Total debt n/a n/a n/a n/a n/a 0.0 885.4 890.8 894.1 793.7
Net cash (debt) n/a n/a n/a n/a n/a 44.5 −722.2 −720.2 −765.1 −608.2
Shareholders’ equity 471.6 560.2 637.9 725.2 840.4 887.4 3,134.2 3,144.1 2,071.2 2,092.9
Debt to equity n/a n/a n/a n/a n/a 0.00 0.28 0.28 0.43 0.38

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2026 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending May, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2010 31 May 2010 FY2011 31 May 2011 FY2012† 31 May 2012 FY2013 31 May 2013 FY2014 31 May 2014 FY2015 31 May 2015 FY2016 31 May 2016 FY2017 31 May 2017 FY2018 31 May 2018 FY2019† 31 May 2019 FY2020 31 May 2020 FY2021 31 May 2021 FY2022 31 May 2022 FY2023† 31 May 2023 FY2024 31 May 2024 FY2025 31 May 2025 FY2026 31 May 2026
Revenue and profit
140.5 172.7 184.0 207.5 247.4 283.1 321.3 358.3 397.9 414.2 418.2 468.5 527.2 822.4 924.2 894.7 870.4
Growth +22.9% +6.6% +12.8% +19.2% +14.4% +13.5% +11.5% +11.1% +4.1% +1.0% +12.0% +12.5% +56.0% +12.4% −3.2% −2.7%
n/a 84.9 91.6 98.0 124.8 143.4 168.2 189.6 211.7 222.3 221.9 253.4 284.1 416.5 460.3 473.3 461.9
73.0 87.8 92.4 109.5 122.6 139.7 153.1 168.9 186.3 191.9 196.3 215.1 243.0 406.0 463.9 421.4 408.5
Growth +20.3% +5.3% +18.5% +12.0% +13.9% +9.6% +10.4% +10.3% +3.0% +2.3% +9.6% +13.0% +67.1% +14.3% −9.2% −3.1%
6.3 6.8 6.6 7.8 8.3 9.6 9.9 10.4 10.9 12.8 14.8 16.2 17.0 26.0 22.5 21.1 18.4
13.5 15.1 17.0 20.2 24.4 25.2 29.2 34.2 38.3 40.8 44.3 51.2 82.7 201.2 199.9 218.2 245.1
26.9 35.8 33.7 40.7 43.4 53.1 56.4 64.9 70.2 68.1 67.5 74.2 58.6 37.5 58.6 −1,061.0 −21.6
Growth +33.3% −5.8% +20.6% +6.6% +22.4% +6.2% +15.2% +8.1% −3.0% −0.8% +9.8% −21.0% −36.0% +56.2% −1,910.6%
27.3 35.2 33.8 41.1 43.0 52.1 55.5 66.7 73.5 73.0 72.3 75.3 60.2 −22.0 −14.3 −1,133.1 −9.0
9.8 12.4 11.5 14.1 15.0 18.5 19.0 22.7 10.3 12.8 12.8 14.4 11.9 0.8 −4.9 −41.1 −1.1
17.5 22.8 22.5 27.2 28.2 33.5 36.6 43.8 63.1 60.2 59.5 60.9 48.3 −22.9 −9.4 −1,092.0 −7.9
Growth +30.4% −1.4% +20.8% +3.6% +19.1% +9.1% +19.8% +44.2% −4.7% −1.2% +2.4% −20.7% −147.3%
Per share
0.78 0.99 0.64 0.76 0.77 0.91 0.73 0.87 1.23 0.58 0.57 0.57 0.45 −0.12 −0.04 −5.03 −0.04
0.76 0.96 0.62 0.75 0.76 0.90 0.72 0.86 1.21 0.57 0.56 0.57 0.45 −0.12 −0.04 −5.03 −0.04
Growth +26.3% −35.4% +21.0% +1.3% +18.4% −20.0% +19.4% +40.7% −52.9% −1.8% +1.8% −21.1% −126.7%
22.4 23.0 35.2 35.8 36.5 37.0 49.9 50.5 51.4 103.8 105.1 106.5 107.7 188.9 216.5 216.9 217.5
23.1 23.8 36.0 36.5 37.3 37.4 50.5 51.2 52.1 104.9 105.7 107.1 108.0 188.9 216.5 216.9 217.5
Growth +3.0% +51.4% +1.3% +2.1% +0.5% +34.9% +1.3% +1.9% +101.1% +0.8% +1.3% +0.8% +74.9% +14.6% +0.2% +0.3%

† The diluted share count jumps at 2012 and 2019 and 2023, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 13.2% a year over five years.
  • Operating margin is down 18.3 points on five years ago, at -2.5%.
  • A net loss in 4 of 17 years on file.